Trial intelligence / Profile preview

Intra-arterial Infusion Chemotherapy Combined With Sodium Bicarbonate and Systemic Chemotherapy for Unresectable Gastric Cancer

NCT03822130Phase 1Unknown

Sponsor
Second Affiliated Hospital of Zhejiang University School of Medicine
Start
Feb 2019
Primary completion
Dec 2020
Modality
Implantable Devices, Transdermal Patches, Inhalation Devices
Countries
1
01

Overview

Phase 1, randomised, open-label trial of sodium bicarbonate ringer's solution in gastric cancer (GC) (3 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Successful conversion rate of operation at 42 days. Status: unknown.

02

Drugs

sodium bicarbonate ringer's solution
03

Conditions

gastric cancer (GC)

Beyond the preview

Go deeper on NCT03822130.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03822130.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call